Oncotype Dx Breast Cancer Assay

What is the Oncotype DX Breast Cancer Assay test?

The Oncotype DX Breast Cancer Assay is a genomic test used in patients with early-stage breast cancer. It analyses the activity of specific genes in tumor tissue to predict the risk of cancer recurrence and assess the potential benefit of chemotherapy.

Why consider Oncotype DX Breast Cancer Assay test?

Oncotype DX breast cancer can be considered for

• To evaluate the likelihood of breast cancer recurrence.
• To help determine whether chemotherapy may be beneficial.
• To support personalized treatment decisions in breast cancer patients.
• To reduce unnecessary chemotherapy in eligible patients.

Who should get tested for the Oncotype DX Breast Cancer Assay?

Oncotype DX breast cancer can be considered for

• Patients diagnosed with early-stage invasive breast cancer.
• Individuals with hormone receptor-positive (HR+) breast cancer.
• Patients with HER2-negative breast cancer.
• Breast cancer patients advised by their oncologist for recurrence risk assessment.

More about the Oncotype DX Breast Cancer Assay

Oncotype DX Breast Cancer Assay test is performed on tumor tissue obtained during surgery or biopsy. It generates a Recurrence Score that helps doctors understand the aggressiveness of the cancer and make informed treatment decisions. This assay is widely used in precision oncology.

Other/Similar names of the test

• Breast Cancer Genomic Assay
• Oncotype Breast Test
• Breast Recurrence Score Test
• Gene Expression Assay for Breast Cancer